Safety and effectiveness of a novel neuroprotectant, KUS121, in patients with non-arteritic central retinal artery occlusion: An open-label, non-randomized, first-in-humans, phase 1/2 trial
scientific article published on 13 February 2020
Author/s
author:
Hanako Ohashi Ikeda,
Masayuki Hata
Wikidata